Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 151,461 | 87,426 | 53,031 | 2,431 | 9,302 |
| Marketable Securities | 258,317 | 211,941 | 21,904 | 18,530 | 18,028 |
| Receivables | 216,509 | 183,857 | 90,680 | 13,863 | 6,371 |
| Other current assets | 32,853 | 40,392 | 30,000 | 6,359 | 3,324 |
| TOTAL | $659,140 | $523,616 | $195,615 | $41,183 | $37,025 |
| Non-Current Assets | |||||
| PPE Net | 46,987 | 40,199 | 17,385 | 6,013 | 5,698 |
| Investments And Advances | 287,626 | 132,502 | 30,656 | 45,833 | 43,917 |
| Other Non-Current Assets | 5,330 | 4,144 | 3,655 | 2,886 | 2,685 |
| TOTAL | $339,943 | $176,845 | $51,696 | $54,732 | $52,300 |
| Total Assets | $999,083 | $700,461 | $247,311 | $95,915 | $89,325 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 15,048 | 15,019 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 17,440 | 26,488 | 18,674 | 3,636 | 2,855 |
| Accrued Expenses | N/A | 8,446 | 5,467 | 1,750 | 2,024 |
| Other current liabilities | 43,520 | 26,843 | N/A | 622 | N/A |
| TOTAL | $196,530 | $130,115 | $57,736 | $6,509 | $5,810 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 987 | 959 | 2,620 | 2,363 | 2,143 |
| TOTAL | $987 | $959 | $2,620 | $2,363 | $2,143 |
| Total Liabilities | $197,517 | $131,074 | $60,356 | $8,872 | $7,953 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,005 | 28,874 | 24,274 | 21,837 | 21,698 |
| Common Shares | 3 | 3 | 2 | 2 | 2 |
| Retained earnings | 350,924 | 150,881 | -15,426 | -62,064 | -65,385 |
| Other shareholders' equity | -216 | 438 | 607 | 1,049 | -193 |
| TOTAL | $801,566 | $569,387 | $186,955 | $87,043 | $81,372 |
| Total Liabilities And Equity | $999,083 | $700,461 | $247,311 | $95,915 | $89,325 |